Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 204

1.

Bacterial delivery of siRNAs: a new approach to solid tumor therapy.

Xu DQ, Zhang L, Kopecko DJ, Gao L, Shao Y, Guo B, Zhao L.

Methods Mol Biol. 2009;487:161-87. doi: 10.1007/978-1-60327-547-7_8.

PMID:
19301647
2.

A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.

Zhao X, Li DC, Zhao H, Li Z, Wang JX, Zhu DM, Zhou J, Cen JN.

Oncol Rep. 2012 Mar;27(3):628-36. doi: 10.3892/or.2011.1602. Epub 2011 Dec 21.

PMID:
22200682
3.

Evaluation of locked nucleic acid-modified small interfering RNA in vitro and in vivo.

Mook OR, Baas F, de Wissel MB, Fluiter K.

Mol Cancer Ther. 2007 Mar;6(3):833-43.

4.

In vivo gene silencing in solid tumors by targeted electrically mediated siRNA delivery.

Golzio M, Mazzolini L, Ledoux A, Paganin A, Izard M, Hellaudais L, Bieth A, Pillaire MJ, Cazaux C, Hoffmann JS, Couderc B, Teissié J.

Gene Ther. 2007 May;14(9):752-9. Epub 2007 Mar 8.

PMID:
17344906
5.

Targeted delivery systems of small interfering RNA by systemic administration.

Kawakami S, Hashida M.

Drug Metab Pharmacokinet. 2007 Jun;22(3):142-51. Review.

6.

Tissue distribution and cancer growth inhibition of magnetic lipoplex-delivered type 1 insulin-like growth factor receptor shRNA in nude mice.

Kong M, Li X, Wang C, Ding C, Dong A, Duan Q, Shen Z.

Acta Biochim Biophys Sin (Shanghai). 2012 Jul;44(7):591-6. doi: 10.1093/abbs/gms039. Epub 2012 May 24.

PMID:
22626974
7.

Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, Wang J, Yu H, Hu J, Kalvakolanu DV, Kopecko DJ, Zhao X, Xu DQ.

Cancer Res. 2007 Jun 15;67(12):5859-64. Erratum in: Cancer Res. 2010 Jul 1;70(13):5639.

8.

Therapeutic potential of RNA interference against cancer.

Takeshita F, Ochiya T.

Cancer Sci. 2006 Aug;97(8):689-96. Review.

9.

Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA.

Wang SL, Yao HH, Guo LL, Dong L, Li SG, Gu YP, Qin ZH.

Cancer Genet Cytogenet. 2009 Apr 1;190(1):8-14. doi: 10.1016/j.cancergencyto.2008.10.013.

PMID:
19264227
10.

Expression of RNA interference triggers from an oncolytic herpes simplex virus results in specific silencing in tumour cells in vitro and tumours in vivo.

Anesti AM, Simpson GR, Price T, Pandha HS, Coffin RS.

BMC Cancer. 2010 Sep 13;10:486. doi: 10.1186/1471-2407-10-486.

11.

[Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].

Zhao WM, Xiu YC, Xu Y, Wang YM, Cheng ZK, Yu Q, Kong DL.

Zhonghua Zhong Liu Za Zhi. 2007 Aug;29(8):575-9. Chinese.

PMID:
18210874
12.

RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy.

Santel A, Aleku M, Keil O, Endruschat J, Esche V, Durieux B, Löffler K, Fechtner M, Röhl T, Fisch G, Dames S, Arnold W, Giese K, Klippel A, Kaufmann J.

Gene Ther. 2006 Sep;13(18):1360-70. Epub 2006 Apr 20.

PMID:
16625242
13.

Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

Spänkuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K.

J Natl Cancer Inst. 2004 Jun 2;96(11):862-72.

14.

Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.

Edovitsky E, Elkin M, Zcharia E, Peretz T, Vlodavsky I.

J Natl Cancer Inst. 2004 Aug 18;96(16):1219-30.

15.

Binary and ternary complexes based on polycaprolactone-graft-poly (N, N-dimethylaminoethyl methacrylate) for targeted siRNA delivery.

Huang Y, Lin D, Jiang Q, Zhang W, Guo S, Xiao P, Zheng S, Wang X, Chen H, Zhang HY, Deng L, Xing J, Du Q, Dong A, Liang Z.

Biomaterials. 2012 Jun;33(18):4653-64. doi: 10.1016/j.biomaterials.2012.02.052. Epub 2012 Apr 3.

PMID:
22480869
16.

Using attenuated Salmonella typhi as tumor targeting vector for MDR1 siRNA delivery.

Jiang Z, Zhao P, Zhou Z, Liu J, Qin L, Wang H.

Cancer Biol Ther. 2007 Apr;6(4):555-60.

PMID:
17374987
17.

Efficient delivery of sticky siRNA and potent gene silencing in a prostate cancer model using a generation 5 triethanolamine-core PAMAM dendrimer.

Liu X, Liu C, Laurini E, Posocco P, Pricl S, Qu F, Rocchi P, Peng L.

Mol Pharm. 2012 Mar 5;9(3):470-81. doi: 10.1021/mp2006104. Epub 2012 Jan 20.

PMID:
22208617
18.

[Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].

Zhang PH, Tu ZG, Yang MQ, Huang WF, Zou L, Zhou YL.

Ai Zheng. 2004 Jun;23(6):619-25. Chinese.

PMID:
15191658
19.

Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.

Pirollo KF, Rait A, Zhou Q, Hwang SH, Dagata JA, Zon G, Hogrefe RI, Palchik G, Chang EH.

Cancer Res. 2007 Apr 1;67(7):2938-43.

20.

Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo.

Zhou J, Peng C, Li B, Wang F, Zhou C, Hong D, Ye F, Cheng X, Lü W, Xie X.

Gynecol Oncol. 2012 Feb;124(2):296-302. doi: 10.1016/j.ygyno.2011.10.028. Epub 2011 Nov 3.

PMID:
22056554
Items per page

Supplemental Content

Write to the Help Desk